Openbookopenbook
Equity
RTW Venture Fund Ltd(RTW)
USD --+0.00%
Reward67High
Risk40Moderate
📊75%Data
Thin -263% profit margin · Revenue growing 937% YoY
RTW
+0.0 · +0.00%
USD · LSE
RTW Venture Fund Ltd | Financial Services
Quality Compounder
Market Cap:64.95Bn
ℹ️
Reward Rating
67
High
Top 25% (model universe)
75% data coverage
ℹ️
Risk Rating
40
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on RTW to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is RTW Venture Fund Ltd?

RTW Biotech Opportunities Ltd is a venture capital fund.

RTW · Verdict

Solid reward · moderate risk

RTW stands out on growth and profitability, but watch the cash flow signal.

Based on 88% data coverage

RTW · Verdict

What’s working & what to watch

Strengths 4

  • Growth87/100

    Top decile vs peers

  • Profitability65/100

    79% net margin · -15% ROE

  • Balance sheet65/100

    Interest covered 7.3×

  • Volatility65/100

    Above average

Watchouts 1

  • Cash flow42/100

    -286% free-cash-flow margin

Model-based scoring. For information only — not financial advice.

What is RTW Venture Fund Ltd?

RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The company is listed on the LSE in UK, operating in the Financial Services sector, with a market capitalisation of 64.95B.

Financial Highlights

Investment Breakdown

📈 Growth
Revenue and earnings growing steadily, indicating improving operating performance.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Risk profile appears balanced versus broad market conditions.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: High (67)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorFinancial Services
Market Cap64.95B
P/E RatioN/A
Dividend YieldN/A
52 Week High2.32
52 Week Low1.08
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding326M
No. of EmployeesN/A
IndustryAsset Management
ExchangeLSE
Beta0.776
CurrencyUSD
Websitewww.rtwfunds.com/rtw-biotech-opportunities
openbook

Stock research for everyday UK investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.